Indonesian Political, Business & Finance News

Esa Medika Mandiri (EMMI) Plans IPO, Targets Rp269 Billion in Fresh Funds

| Source: CNBC Indonesia Translated from Indonesian | Finance
Esa Medika Mandiri (EMMI) Plans IPO, Targets Rp269 Billion in Fresh Funds
Image: CNBC Indonesia

PT Esa Medika Mandiri Tbk (EMMI), a prospective issuer specialising in the distribution of laboratory, pharmaceutical, and medical equipment, plans to conduct an Initial Public Offering (IPO) by offering up to 522.86 million new shares.

According to the latest prospectus, this amount represents a maximum of 30% of the company’s placed and fully paid-up capital after the IPO.

In this corporate action, the company is offering shares within a price range of Rp446 to Rp515 per share. Consequently, the potential funds raised could reach a maximum of Rp269.27 billion.

The company has also allocated up to 52.29 million shares, equivalent to 10% of the offered shares, for the Employee Stock Allocation (ESA) programme.

The IPO is underwritten via a full commitment scheme by PT BRI Danareksa Sekuritas and PT INA Sekuritas Indonesia as the underwriters. The public offering period is expected to take place from 2–6 July 2026, with the listing on the Indonesia Stock Exchange (IDX) scheduled for 8 July 2026.

In terms of performance, PT Esa Medika Mandiri recorded a profit of Rp34.13 billion for the 2025 fiscal year. This achievement represents a significant increase compared to the previous year’s profit of Rp11 billion.

Meanwhile, the company’s net sales throughout 2025 reached Rp454.63 billion.

At the time of its establishment, the company’s shareholding structure consisted of Surya Gunawan Widjaja with 55%, Eddy Lie with 35%, and Andre Fajar Surya Gunawan with 10%.

All proceeds from the IPO, after deducting issuance costs, will be used to support the strengthening of the financial structure and business expansion. Approximately Rp50 billion will be allocated to the repayment of part of the company’s loan principal.

Furthermore, about 11.8% of the IPO proceeds will be used for business development through capital expenditure, specifically for the construction of a factory building in Cikupa. Approximately 68.7% will be used as working capital, including the purchase of project-related goods and the procurement of raw materials and inventory.

More from 22 June 2026 →

Cite this article
Source: jawawa.id (https://jawawa.id/newsitem/esa-medika-mandiri-emmi-plans-ipo-targets-rp269-billion-in-fresh-funds-1782107506)
Originally published by CNBC Indonesia (https://www.cnbcindonesia.com/market/20260622113810-17-744571/esa-medika-mandiri--emmi--mau-ipo-incar-dana-segar-rp269-miliar), translated from Indonesian
Print